Mary Ziping Luo
2014
In 2014, Mary Ziping Luo earned a total compensation of $2.7M as Chief Operating Officer, Chief Scientist and Chairman at Amphastar Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $405,579 |
|---|---|
| Option Awards | $535,000 |
| Salary | $719,723 |
| Stock Awards | $993,000 |
| Other | $31,345 |
| Total | $2,684,647 |
Luo received $993K in stock awards, accounting for 37% of the total pay in 2014.
Luo also received $405.6K in bonus, $535K in option awards, $719.7K in salary and $31.3K in other compensation.
Rankings
In 2014, Mary Ziping Luo's compensation ranked 3,376th out of 13,032 executives tracked by ExecPay. In other words, Luo earned more than 74.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,376 out of 13,032 | 74th |
Division Manufacturing | 1,193 out of 4,965 | 76th |
Major group Chemicals And Allied Products | 388 out of 1,690 | 77th |
Industry group Drugs | 302 out of 1,369 | 78th |
Industry Pharmaceutical Preparations | 245 out of 1,042 | 77th |
Source: SEC filing on April 22, 2016.
Luo's colleagues
We found two more compensation records of executives who worked with Mary Ziping Luo at Amphastar Pharmaceuticals in 2014.
News
Amphastar Pharmaceuticals CEO Jack Zhang's 2021 pay rises 9% to $6.5M
April 14, 2022
Amphastar Pharmaceuticals General Counsel Jason Shandell's 2020 pay jumps 132% to $6.8M
April 14, 2021
Amphastar Pharmaceuticals CEO Jack Zhang's 2019 pay rises 2% to $6M
April 15, 2020
Amphastar Pharmaceuticals CEO Jack Zhang's 2018 pay rises 2% to $5.9M
April 18, 2019